BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 28216017)

  • 21. USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein.
    Ali A; Raja R; Farooqui SR; Ahmad S; Banerjea AC
    Biochem J; 2017 May; 474(10):1653-1668. PubMed ID: 28280111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt/β-catenin pathway via Axin1 deubiquitination.
    Huang T; Zhang Q; Ren W; Yan B; Yi L; Tang T; Lin H; Zhang Y
    Cell Biol Int; 2020 Aug; 44(8):1651-1659. PubMed ID: 32285989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. USP7 inactivation suppresses APC-mutant intestinal hyperproliferation and tumor development.
    Novellasdemunt L; Kucharska A; Baulies A; Hutton C; Vlachogiannis G; Repana D; Rowan A; Suárez-Bonnet A; Ciccarelli F; Valeri N; Li VSW
    Stem Cell Reports; 2023 Feb; 18(2):570-584. PubMed ID: 36669491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of USP7 and MARCH7 Is Correlated with Poor Prognosis in Epithelial Ovarian Cancer.
    Zhang L; Wang H; Tian L; Li H
    Tohoku J Exp Med; 2016 Jul; 239(3):165-75. PubMed ID: 27302477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the overexpressed USP7 inhibits esophageal squamous cell carcinoma cell growth by inducing NOXA-mediated apoptosis.
    Hu T; Zhang J; Sha B; Li M; Wang L; Zhang Y; Liu X; Dong Z; Liu Z; Li P; Chen P
    Mol Carcinog; 2019 Jan; 58(1):42-54. PubMed ID: 30182448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. USP7 inhibits Wnt/β-catenin signaling through promoting stabilization of Axin.
    Ji L; Lu B; Zamponi R; Charlat O; Aversa R; Yang Z; Sigoillot F; Zhu X; Hu T; Reece-Hoyes JS; Russ C; Michaud G; Tchorz JS; Jiang X; Cong F
    Nat Commun; 2019 Sep; 10(1):4184. PubMed ID: 31519875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YAP-dependent ubiquitination and degradation of β-catenin mediates inhibition of Wnt signalling induced by Physalin F in colorectal cancer.
    Chen C; Zhu D; Zhang H; Han C; Xue G; Zhu T; Luo J; Kong L
    Cell Death Dis; 2018 May; 9(6):591. PubMed ID: 29789528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.
    He Y; Wang S; Tong J; Jiang S; Yang Y; Zhang Z; Xu Y; Zeng Y; Cao B; Moran MF; Mao X
    J Biol Chem; 2020 Feb; 295(7):2084-2096. PubMed ID: 31822558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitin specific protease 4 positively regulates the WNT/β-catenin signaling in colorectal cancer.
    Yun SI; Kim HH; Yoon JH; Park WS; Hahn MJ; Kim HC; Chung CH; Kim KK
    Mol Oncol; 2015 Nov; 9(9):1834-51. PubMed ID: 26189775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINC00265 promotes colorectal tumorigenesis via ZMIZ2 and USP7-mediated stabilization of β-catenin.
    Zhu Y; Gu L; Lin X; Cui K; Liu C; Lu B; Zhou F; Zhao Q; Shen H; Li Y
    Cell Death Differ; 2020 Apr; 27(4):1316-1327. PubMed ID: 31527801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/beta-catenin pathway.
    Li LN; Zhang HD; Yuan SJ; Tian ZY; Wang L; Sun ZX
    Int J Cancer; 2007 Sep; 121(6):1360-5. PubMed ID: 17520675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. USP7 inhibition inhibits proliferation and induces megakaryocytic differentiation in MDS cells by upregulating gelsolin.
    Deng J; Liang L; Yi H; Su T; Yang Z; Nie L; Liu J
    Br J Haematol; 2020 Aug; 190(3):418-429. PubMed ID: 32130729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation and Validation of Intracellular Ubiquitin Variant Inhibitors for USP7 and USP10.
    Zhang W; Sartori MA; Makhnevych T; Federowicz KE; Dong X; Liu L; Nim S; Dong A; Yang J; Li Y; Haddad D; Ernst A; Heerding D; Tong Y; Moffat J; Sidhu SS
    J Mol Biol; 2017 Nov; 429(22):3546-3560. PubMed ID: 28587923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity.
    He Y; Li W; Lv D; Zhang X; Zhang X; Ortiz YT; Budamagunta V; Campisi J; Zheng G; Zhou D
    Aging Cell; 2020 Mar; 19(3):e13117. PubMed ID: 32064756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FAM188B enhances cell survival via interaction with USP7.
    Choi ES; Lee H; Sung JY; Lee CH; Jang H; Kim KT; Kim YN; Kim HP; Goh SH
    Cell Death Dis; 2018 May; 9(6):633. PubMed ID: 29795372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZRANB1 enhances stem-cell-like features and accelerates tumor progression by regulating Sox9-mediated USP22/Wnt/β-catenin pathway in colorectal cancer.
    Miao D; Wang Y; Jia Y; Tong J; Jiang S; Liu L
    Cell Signal; 2022 Feb; 90():110200. PubMed ID: 34798260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133
    Klose J; Eissele J; Volz C; Schmitt S; Ritter A; Ying S; Schmidt T; Heger U; Schneider M; Ulrich A
    BMC Cancer; 2016 Nov; 16(1):896. PubMed ID: 27855654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
    Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
    Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.